FIGURE 2.

Network pharmacology analysis of key compounds in plasma. (A) Top 20 targets of PPI; (B) molecular docking results of the key compounds in plasma with top five targets of PPI; (C) GO enrichment of the key compounds in plasma; (D) pathway-target diagram of key compounds in plasma.